Toggle Nav
Close
  • Menu
  • Setting

Anti-CTLA-4/CD152 Antibody (Ipilimumab)

Catalog No.
F1221
Anti-CTLA-4/CD152 Antibody (Ipilimumab)
Grouped product items
SizePriceStock Qty
100ug
$156.00
Ship with 3-5 days
1mg
$468.00
Ship with 3-5 days
5mg
$1,217.00
Ship with 3-5 days
50mg
$4,088.00
Ship with 3-5 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Ipilimumab is a fully human monoclonal IgG1κ antibody that blocks the inhibitory receptor cytotoxic T lymphocyte antigen 4 (CTLA-4) on T cells. Ipilimumab is being studied in unresectable or metastatic melanoma (MM).

Quality Control

Quality Control & DataSheet

View current batch:
 

M.Wt

145.38 kDa

Shipping

Dry ice

Cas No.

477202-00-9

Storage

-80°C

Expiration Date

2 years

Form

Liquid

Concentration

See label

Reconstitution

For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.

Host

CHO

Alternative Names

Yervoy, MDX-010, MDX101

Buffer System

100 mM Pro 20 mM Arg pH 5.0. No preservative!

Target Accession

P16410

Reactivity

Human, Cynomolgus

Conjugation

Unconjugated

Clonality

Monoclonal

Purification

Protein A

Isotype

IgG1

Application

ELISA, FACS, Kinetics, Functional assay, Animal Model

Biological Activity

Human CTLA-4 & Human PD-1 CHO-K cells were stained with Anti-CTLA-4 / CD152 Reference Antibody (ipilimumab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS

Target

CTLA-4 / CD152

Note

Please avoid freeze-thaw cycles.